Cargando…

Mesenchymal Stem Cell Therapy in Diabetes Mellitus: Progress and Challenges

Advanced type 2 diabetes mellitus is associated with significant morbidity and mortality due to cardiovascular, nervous, and renal complications. Attempts to cure diabetes mellitus using islet transplantation have been successful in providing a source for insulin secreting cells. However, limited do...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Badri, Nagwa, Ghoneim, Mohamed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666198/ https://www.ncbi.nlm.nih.gov/pubmed/23762531 http://dx.doi.org/10.1155/2013/194858

Ejemplares similares

Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis
por: El-Badawy, Ahmed, et al.
Publicado: (2016)

Mesenchymal Stromal Cell Therapy for Pancreatitis: A Systematic Review
por: Ahmed, Sara M., et al.
Publicado: (2018)

Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state
por: El-Badawy, Ahmed, et al.
Publicado: (2017)

The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis
por: Sharaf-Eldin, Wessam E., et al.
Publicado: (2016)

Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells
por: El-Badawy, Ahmed, et al.
Publicado: (2018)

From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges
por: Ghoneim, Mohamed A., et al.
Publicado: (2020)

Generation of Insulin-Producing Cells from Human Bone Marrow-Derived Mesenchymal Stem Cells: Comparison of Three Differentiation Protocols
por: Gabr, Mahmoud M., et al.
Publicado: (2014)

The cell cycle as a brake for β-cell regeneration from embryonic stem cells
por: El-Badawy, Ahmed, et al.
Publicado: (2016)

Mesenchymal stem cell therapy in type 2 diabetes mellitus
por: Zang, Li, et al.
Publicado: (2017)

Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells
por: Nasr, Mohamed A., et al.
Publicado: (2019)

Current progress in stem cell therapy for type 1 diabetes mellitus
por: Chen, Shuai, et al.
Publicado: (2020)

From Human Mesenchymal Stem Cells to Insulin-Producing Cells: Comparison between Bone Marrow- and Adipose Tissue-Derived Cells
por: Gabr, Mahmoud M., et al.
Publicado: (2017)

Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications
por: Sun, Fengtian, et al.
Publicado: (2022)

Applications of the amniotic membrane in tissue engineering and regeneration: the hundred-year challenge
por: Elkhenany, Hoda, et al.
Publicado: (2022)

Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
por: Huang, Qiulan, et al.
Publicado: (2021)

Stem cell therapy for diabetes mellitus
por: Voltarelli, Júlio C, et al.
Publicado: (2011)

Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer’s disease: progress, advantages, and challenges
por: Gonçalves, Renata Guedes de Jesus, et al.
Publicado: (2022)

Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus
por: Mikłosz, Agnieszka, et al.
Publicado: (2023)

Challenges and Controversies in Human Mesenchymal Stem Cell Therapy
por: Lukomska, Barbara, et al.
Publicado: (2019)

Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
por: Rekittke, Nadine E., et al.
Publicado: (2016)

Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy
por: da Silva, Jaqueline S., et al.
Publicado: (2022)

Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke
por: Guo, Yinghan, et al.
Publicado: (2021)

Correction: Immunoinformatics approach of epitope prediction for SARS-CoV-2
por: Awad, Nourelislam, et al.
Publicado: (2022)

Immunoinformatics approach of epitope prediction for SARS-CoV-2
por: Awad, Nourelislam, et al.
Publicado: (2022)

Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges
por: Chen, Fukun, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy for Stroke: Challenges and Progress
por: Bang, Oh Young, et al.
Publicado: (2019)

Adult Stem Cell Therapy for Stroke: Challenges and Progress
por: Bang, Oh Young, et al.
Publicado: (2016)

Stem Cell Therapies in Kidney Diseases: Progress and Challenges
por: Rota, Cinzia, et al.
Publicado: (2019)

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
por: Volarevic, Vladislav, et al.
Publicado: (2011)

Diabetes mellitus: new challenges and innovative therapies
por: Sena, Cristina M., et al.
Publicado: (2010)

Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
por: Paulini, Janaina, et al.
Publicado: (2016)

Stem Cell Therapy for Thyroid Diseases: Progress and Challenges
por: Ye, Sunyi, et al.
Publicado: (2022)

Mesenchymal stem cell therapy for liver disease: full of chances and challenges
por: Yang, Xue, et al.
Publicado: (2020)

Research Progress on Mesenchymal Stem Cells for the Treatment of Diabetes and Its Complications
por: Zhang, Jiarui, et al.
Publicado: (2023)

Progress in mesenchymal stem cell–based therapy for acute liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2018)

Regulators of pluripotency and their implications in regenerative medicine
por: El-Badawy, Ahmed, et al.
Publicado: (2015)

Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges
por: Ma, Zhilong, et al.
Publicado: (2023)

Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson’s disease
por: Fričová, Dominika, et al.
Publicado: (2020)

Wharton’s jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis
por: Hammam, Olfat A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rt5nhuf1q83fkoglb0vo49hvlb